Clinical trial
APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary…
NCT00138034 · Heartcenter, University Medical Center St. Radboud, Other · Completed
Key facts
| NCT number | NCT00138034 |
|---|---|
| Title | APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3 |
| Official title | A Multicenter Randomized Trial in the Prevention of Reocclusion Following Successful Thrombolysis for Suspected Acute Myocardial Infarction: An Invasive Versus a Conservative Strategy |
| Lead sponsor | Heartcenter, University Medical Center St. Radboud, Other |
| Collaborators | Netherlands Heart Foundation The Interuniversity Cardiology Institute of the Netherlands Pfizer Industry Sanofi |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Procedure |
| Interventions | Percutaneous coronary intervention (PCI) |
| Enrollment | 49 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Aug 30, 2005 |
| Last update posted | Apr 30, 2012 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: